Literature DB >> 17179357

Dynamic CT for detecting small hepatocellular carcinoma: usefulness of delayed phase imaging.

Shuichi Monzawa1, Tomoaki Ichikawa, Hiroto Nakajima, Yuki Kitanaka, Kosaku Omata, Tsutomu Araki.   

Abstract

OBJECTIVE: The purpose of this retrospective study was to determine the usefulness of delayed phase imaging for detecting small (< or = 2 cm) hepatocellular carcinomas (HCCs) in patients with liver cirrhosis.
MATERIALS AND METHODS: Triphasic (arterial, portal venous, and delayed phases) dynamic CT was performed in 33 patients with 48 HCCs proven histopathologically and in 65 control subjects. Arterial, portal venous, and delayed phase images were obtained 30 seconds, 68-70 seconds, and 5 minutes after the start of contrast material injection, respectively. Three blinded observers reviewed the images independently and evaluated tumor attenuation. Diagnostic performance for the combination of phases was assessed using receiver operating characteristic (ROC) curve analysis.
RESULTS: On arterial phase images, 28 of the 48 HCCs were hyperattenuating, nine were isoattenuating, and 11 were hypoattenuating. On portal venous phase images, three tumors were hyperattenuating, 17 were isoattenuating, and 28 were hypoattenuating. On delayed phase images, five tumors were isoattenuating, and 43 were hypoattenuating. The mean sensitivity for the combination of arterial and portal venous phase imaging was 86.8%, that for the combination of arterial and delayed phase imaging was 90.3%, and that for the combination of all three phase imaging was 93.8%. The area underneath composite ROC curve (A(Z)) for the combination of all three phase imaging (A(Z) = 0.940) was significantly higher than that for the combination of arterial and portal venous phase imaging (A(Z) = 0.917) and for the combination of arterial and delayed phase imaging (A(Z) = 0.922).
CONCLUSION: Delayed phase imaging is useful for detecting small HCCs and should be included in dynamic CT examinations of patients with liver cirrhosis.

Entities:  

Mesh:

Year:  2007        PMID: 17179357     DOI: 10.2214/AJR.05.0512

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  29 in total

1.  Needle track seeding following percutaneous procedures for hepatocellular carcinoma.

Authors:  Giuseppe Cabibbo; Antonio Craxì
Journal:  World J Hepatol       Date:  2009-10-31

2.  Perfusion computed tomography for detection of hepatocellular carcinoma in patients with liver cirrhosis.

Authors:  Michael A Fischer; Nikolaos Kartalis; Aristeidis Grigoriadis; Louiza Loizou; Per Stål; Bertil Leidner; Peter Aspelin; Torkel B Brismar
Journal:  Eur Radiol       Date:  2015-04-23       Impact factor: 5.315

3.  The added diagnostic value of 64-row multidetector CT combined with contrast-enhanced US in the evaluation of hepatocellular nodule vascularity: implications in the diagnosis of malignancy in patients with liver cirrhosis.

Authors:  Emilio Quaia; Valerio Alaimo; Elisa Baratella; Alessandro Medeot; Massimo Midiri; Maria Assunta Cova
Journal:  Eur Radiol       Date:  2008-09-25       Impact factor: 5.315

4.  Multidetector-row computed tomography (MDCT) for the diagnosis of hepatocellular carcinoma in cirrhotic candidates for liver transplantation: prevalence of radiological vascular patterns and histological correlation with liver explants.

Authors:  Angelo Luca; Settimo Caruso; Mariapina Milazzo; Giuseppe Mamone; Gianluca Marrone; Roberto Miraglia; Luigi Maruzzelli; Vincenzo Carollo; Marta Ida Minervini; Giovanni Vizzini; Salvatore Gruttadauria; Salvatore Grutttadauria; Bruno Gridelli
Journal:  Eur Radiol       Date:  2009-10-03       Impact factor: 5.315

5.  Extracellular contrast agent-enhanced MRI: 15-min delayed phase may improve the diagnostic performance for hepatocellular carcinoma in patients with chronic liver disease.

Authors:  Si Eun Lee; Chansik An; Shin Hye Hwang; Jin-Young Choi; Kyunghwa Han; Myeong-Jin Kim
Journal:  Eur Radiol       Date:  2017-11-13       Impact factor: 5.315

6.  Histologic characteristics of hepatocellular carcinomas showing atypical enhancement patterns on 4-phase MDCT examination.

Authors:  Injoong Kim; Myeong-Jin Kim
Journal:  Korean J Radiol       Date:  2012-08-28       Impact factor: 3.500

7.  Is liver-specific gadoxetic acid-enhanced magnetic resonance imaging a reliable tool for detection of hepatocellular carcinoma in patients with chronic liver disease?

Authors:  Lian-Ming Wu; Jian-Rong Xu; Hai-Yan Gu; Jia Hua; Jie Chen; Jiong Zhu; Wei Zhang; Jiani Hu
Journal:  Dig Dis Sci       Date:  2013-07-25       Impact factor: 3.199

8.  Volumetric low-tube-voltage CT imaging for evaluating hypervascular hepatocellular carcinoma; effects on radiation exposure, image quality, and diagnostic performance.

Authors:  Tomoaki Ichikawa; Utaroh Motosugi; Hiroyuki Morisaka; Katsuhiro Sano; Muhi Ali; Tsutomu Araki
Journal:  Jpn J Radiol       Date:  2013-06-22       Impact factor: 2.374

9.  Adaptive statistical iterative reconstruction for volume-rendered computed tomography portovenography: improvement of image quality.

Authors:  Izuru Matsuda; Shohei Hanaoka; Masaaki Akahane; Jiro Sato; Shuuhei Komatsu; Shinichi Inoh; Shigeru Kiryu; Naoki Yoshioka; Kenji Ino; Kuni Ohtomo
Journal:  Jpn J Radiol       Date:  2010-11-27       Impact factor: 2.374

10.  Hepatocellular carcinoma: management of an increasingly common problem.

Authors:  Gary L Davis; Jane Dempster; James D Meler; Douglas W Orr; Mark W Walberg; Brian Brown; Brian D Berger; John K O'Connor; Robert M Goldstein
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.